Stroke Trial, Recruiting (NCT06121336)

Stroke Trial, Recruiting NCT06121336 Sponsor: Ludwig-Maximilians - University of Munich Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06121336 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been clinically diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain)
People whose stroke symptoms began within the last 9 hours
People who have a blockage in one of the major or medium-sized blood vessels in the brain, confirmed by a CT or MRI scan with vessel imaging
People who are at least 18 years old
People who are able to provide written consent to participate

Who may not be able to join:

People whose CT or MRI scan shows bleeding in the brain at the time of admission
People who have had a stroke, brain bleed, blood clot around the brain, brain tumour, or certain brain infections (such as meningitis or encephalitis) within the last three months
People with severely reduced kidney function (confirm with trial site)
People who have been diagnosed with dementia
People who already had some level of disability before the stroke, specifically a score of more than 1 on a standard disability scale called the modified Rankin Scale (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4989440046046

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06121336

Sponsor: Ludwig-Maximilians - University of Munich

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +4989440046046

More information: https://clinicaltrials.gov/study/NCT06121336

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been clinically diagnosed with an acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain)
People whose stroke symptoms began within the last 9 hours
People who have a blockage in one of the major or medium-sized blood vessels in the brain, confirmed by a CT or MRI scan with vessel imaging
People who are at least 18 years old
People who are able to provide written consent to participate

Who may not be able to join:

People whose CT or MRI scan shows bleeding in the brain at the time of admission
People who have had a stroke, brain bleed, blood clot around the brain, brain tumour, or certain brain infections (such as meningitis or encephalitis) within the last three months
People with severely reduced kidney function (confirm with trial site)
People who have been diagnosed with dementia
People who already had some level of disability before the stroke, specifically a score of more than 1 on a standard disability scale called the modified Rankin Scale (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Ludwig-Maximilians - University of Munich

Registry

ClinicalTrials.gov

Start date

1 March 2023

Est. completion

30 June 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

The primary outcome are plasma BD-tau levels in acute ischemic stroke.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov